XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Investments in Unconsolidated Ventures - Summary of Investments in Unconsolidated Ventures (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]            
Equity in earnings (losses) of unconsolidated ventures   $ (127,000) $ 2,872,000   $ (6,595,000) $ 39,427,000
Cash Distribution   0 4,033,000   24,112,000 42,173,000
Distributions from unconsolidated ventures         10,640,000 0
Impairment recognized           0
Trilogy            
Schedule of Equity Method Investments [Line Items]            
Equity in earnings (losses) of unconsolidated ventures   (146,000) 6,052,000   454,000 10,757,000
Cash Distribution   0 2,300,000   4,668,000 6,900,000
Espresso Joint Venture            
Schedule of Equity Method Investments [Line Items]            
Equity in earnings (losses) of unconsolidated ventures   0 (242,000)   9,228,000 33,711,000
Cash Distribution   0 1,375,000   19,444,000 32,363,000
Equity method investment, realized gain on disposal         9,200,000 32,000,000
Distributions from unconsolidated ventures         17,300,000 27,400,000
Impairment recognized $ 4,700,000     $ 4,700,000 4,700,000  
Solstice            
Schedule of Equity Method Investments [Line Items]            
Equity in earnings (losses) of unconsolidated ventures   19,000 17,000   (41,000) (41,000)
Cash Distribution   0 0   0 0
Trilogy, Espresso, Solstice            
Schedule of Equity Method Investments [Line Items]            
Equity in earnings (losses) of unconsolidated ventures   0 (2,955,000)   (16,236,000) (5,000,000)
Cash Distribution   $ 0 $ 358,000   0 $ 2,910,000
Diversified US/UK            
Schedule of Equity Method Investments [Line Items]            
Impairment recognized         $ 11,400,000